Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Venous Thrombosis

Free Subscription Articles published in Thromb Res Retrieve available abstracts of 178 articles: HTML format Text format

Single Articles

November 2018
1. ZUIN M, Rigatelli G, Carraro M, Pastore G, et al
   Systemic thrombolysis in haemodynamically unstable pulmonary embolism: The earlier the better?
   Thromb Res. 2018;173:117-123.
   PubMed     Text format     Abstract available
   
   
   
2. LI M, Guo Q, Hu W
   Incidence, risk factors, and outcomes of venous thromboembolism after oncologic surgery: A systematic review and meta-analysis.
   Thromb Res. 2018;173:48-56.
   PubMed     Text format     Abstract available
   
   
   
3. HAU A, Wegener E, Ignjatovic V, Revel-Vilk S, et al
   Family history of venous thromboembolism in the paediatric population: The need for a standardized definition.
   Thromb Res. 2018;173:91-95.
   PubMed     Text format     Abstract available
   
   
   October 2018
4. HOUGHTON DE, Alsawas M, Barrioneuvo P, Tello M, et al
   Testosterone therapy and venous thromboembolism: A systematic review and meta-analysis.
   Thromb Res. 2018;172:94-103.
   PubMed     Text format     Abstract available
   
   
   
5. HAGAN KA, Harrington LB, Kim J, Lindstrom S, et al
   Adiposity throughout the life course and risk of venous thromboembolism.
   Thromb Res. 2018;172:67-73.
   PubMed     Text format     Abstract available
   
   
   
6. LIN YC, Lee SH, Chen IJ, Chang CH, et al
   Symptomatic pulmonary embolism following hip fracture: A nationwide study.
   Thromb Res. 2018;172:120-127.
   PubMed     Text format     Abstract available
   
   
   September 2018
7. BARCO S, Klok FA, Mahe I, Marchena PJ, et al
   Impact of sex, age, and risk factors for venous thromboembolism on the initial presentation of first isolated symptomatic acute deep vein thrombosis.
   Thromb Res. 2018 Sep 27. pii: S0049-3848(18)30547.
   PubMed     Text format     Abstract available
   
   
   
8. BAYAM E, Kalcik M, Gurbuz AS, Yesin M, et al
   The relationship between heparanase levels, thrombus burden and thromboembolism in patients receiving unfractionated heparin treatment for prosthetic valve thrombosis.
   Thromb Res. 2018;171:103-110.
   PubMed     Text format     Abstract available
   
   
   
9. ROBIN P, Otten HM, Delluc A, van Es N, et al
   Effect of occult cancer screening on mortality in patients with unprovoked venous thromboembolism.
   Thromb Res. 2018;171:92-96.
   PubMed     Text format     Abstract available
   
   
   
10. MOUSTAFA F, Stehouwer A, Kamphuisen P, Sahuquillo JC, et al
    Management and outcome of major bleeding in patients receiving vitamin K antagonists for venous thromboembolism.
    Thromb Res. 2018;171:74-80.
    PubMed     Text format     Abstract available
    
    
    
11. TAVOLY M, Wik HS, Sirnes PA, Jelsness-Jorgensen LP, et al
    The impact of post-pulmonary embolism syndrome and its possible determinants.
    Thromb Res. 2018;171:84-91.
    PubMed     Text format     Abstract available
    
    
    
12. VEDOVATI MC, Giustozzi M, Bonitta G, Agnelli G, et al
    Efficacy and safety of anticoagulant agents in patients with venous thromboembolism and cancer: A network meta-analysis.
    Thromb Res. 2018;170:175-180.
    PubMed     Text format     Abstract available
    
    
    August 2018
13. GOYARD C, Cote B, Looten V, Roche A, et al
    Determinants and prognostic implication of diagnostic delay in patients with a first episode of pulmonary embolism.
    Thromb Res. 2018 Aug 26. pii: S0049-3848(18)30475.
    PubMed     Text format     Abstract available
    
    
    
14. TEN CATE H, Lensing AWA, Weitz JI, Middeldorp S, et al
    The prothrombin time does not predict the risk of recurrent venous thromboembolism or major bleeding in rivaroxaban-treated patients.
    Thromb Res. 2018;170:75-83.
    PubMed     Text format     Abstract available
    
    
    
15. KUNUTSOR SK, Beswick AD, Whitehouse MR, Blom AW, et al
    Systematic review of risk prediction scores for venous thromboembolism following joint replacement.
    Thromb Res. 2018;168:148-155.
    PubMed     Text format     Abstract available
    
    
    
16. PRANDONI P, Lensing AWA, Prins MH, Gebel M, et al
    Benefits and risks of extended treatment of venous thromboembolism with rivaroxaban or with aspirin.
    Thromb Res. 2018;168:121-129.
    PubMed     Text format     Abstract available
    
    
    July 2018
17. CHEUNG KL, Bouchard BA, Cushman M
    Venous thromboembolism, factor VIII and chronic kidney disease.
    Thromb Res. 2018;170:10-19.
    PubMed     Text format     Abstract available
    
    
    
18. PATANWALA AE, Seaman SM, Kopp BJ, Erstad BL, et al
    Heparin dosing for venous thromboembolism prophylaxis in obese hospitalized patients: An observational study.
    Thromb Res. 2018;169:152-156.
    PubMed     Text format     Abstract available
    
    
    
19. RODGER MA, Le Gal G, Langlois NJ, Gin B, et al
    "HERDOO2" clinical decision rule to guide duration of anticoagulation in women with unprovoked venous thromboembolism. Can I use any d-Dimer?
    Thromb Res. 2018;169:82-86.
    PubMed     Text format     Abstract available
    
    
    
20. LUNDBECH M, Krag AE, Hvas AM
    Prevalence of venous thromboembolism following head and neck cancer surgery: A systematic review and meta-analysis.
    Thromb Res. 2018;169:30-34.
    PubMed     Text format    
    
    
    
21. DI NISIO M, Candeloro M, Rutjes AWS, Galli V, et al
    Bleeding and venous thromboembolic events in patients with active cancer hospitalized for an acute medical illness.
    Thromb Res. 2018;169:44-49.
    PubMed     Text format     Abstract available
    
    
    
22. CHATURVEDI S, Kohli R, Schaefer N, Clancy M, et al
    Characteristics and outcomes of venous thromboembolism in patients with hereditary hemorrhagic telangiectasia.
    Thromb Res. 2018;169:41-43.
    PubMed     Text format    
    
    
    June 2018
23. HOILAND II, Liang RA, Hindberg K, Latysheva N, et al
    Associations between complement pathways activity, mannose-binding lectin, and odds of unprovoked venous thromboembolism.
    Thromb Res. 2018;169:50-56.
    PubMed     Text format     Abstract available
    
    
    
24. ROVINSKI D, Ramos RB, Fighera TM, Casanova GK, et al
    Risk of venous thromboembolism events in postmenopausal women using oral versus non-oral hormone therapy: A systematic review and meta-analysis.
    Thromb Res. 2018;168:83-95.
    PubMed     Text format     Abstract available
    
    
    
25. SCAGLIOLA R
    Electrocardiographic changes in pulmonary embolism: Each lead could be a clue in solving the puzzle.
    Thromb Res. 2018;168:78-79.
    PubMed     Text format    
    
    
    
26. CROLES FN, Mulder R, Mulder AB, Lukens MV, et al
    beta-Antithrombin, subtype of antithrombin deficiency and the risk of venous thromboembolism in hereditary antithrombin deficiency: A family cohort study.
    Thromb Res. 2018;168:47-52.
    PubMed     Text format     Abstract available
    
    
    
27. DELLUC A, Clemons M
    Poor outcomes after venous thromboembolism in cancer patients: It's time to change practice.
    Thromb Res. 2018 Jun 2. pii: S0049-3848(18)30377.
    PubMed     Text format    
    
    
    May 2018
28. SALIBA W, Warwar A, Kotler A, Cohen S, et al
    Association of factor V activity with risk of venous thromboembolism and atherothrombotic cardiovascular events: A retrospective population-based cohort study.
    Thromb Res. 2018;168:14-19.
    PubMed     Text format     Abstract available
    
    
    
29. COLEMAN CI, Peacock WF, Bunz TJ, Beyer-Westendorf J, et al
    Effectiveness and safety of rivaroxaban versus warfarin in patients with unprovoked venous thromboembolism: A propensity-score weighted administrative claims cohort study.
    Thromb Res. 2018;168:31-36.
    PubMed     Text format     Abstract available
    
    
    
30. MOESKER MJ, Damen NL, Volmeijer EE, Dreesens D, et al
    Guidelines' risk assessment recommendations for venous thromboembolism prophylaxis: A comparison and implementability appraisal.
    Thromb Res. 2018;168:5-13.
    PubMed     Text format     Abstract available
    
    
    
31. KLINE JA, Ellison AM, Kanis J, Pike JW, et al
    Evaluation of the pulmonary embolism rule out criteria (PERC rule) in children evaluated for suspected pulmonary embolism.
    Thromb Res. 2018;168:1-4.
    PubMed     Text format     Abstract available
    
    
    
32. FEEHAN M, Walsh M, Van Duker H, Godin J, et al
    Prevalence and correlates of bleeding and emotional harms in a national US sample of patients with venous thromboembolism: A cross-sectional structural equation model.
    Thromb Res. 2018 May 23. pii: S0049-3848(18)30366.
    PubMed     Text format     Abstract available
    
    
    
33. DRONKERS CEA, Lijfering WM, Teichert M, van der Meer FJM, et al
    Persistence to direct oral anticoagulants for acute venous thromboembolism.
    Thromb Res. 2018;167:135-141.
    PubMed     Text format     Abstract available
    
    
    
34. BURSTEIN B, Barbosa RS, Kalfon E, Joza J, et al
    Pulmonary embolism after electrophysiology procedures: Incidence from a single centre registry.
    Thromb Res. 2018;167:125-127.
    PubMed     Text format    
    
    
    
35. VANNI S, Becattini C, Nazerian P, Bova C, et al
    Early discharge of patients with pulmonary embolism in daily clinical practice: A prospective observational study comparing clinical gestalt and clinical rules.
    Thromb Res. 2018;167:37-43.
    PubMed     Text format     Abstract available
    
    
    
36. YOUNG K, Paz-Ares L, Thatcher N, Spigel DR, et al
    Venous thromboembolism with EGFR monoclonal antibody necitumumab in stage IV non-small cell lung cancer: A retrospective cohort analysis.
    Thromb Res. 2018;167:50-56.
    PubMed     Text format     Abstract available
    
    
    
37. LAZO-LANGNER A, Al-Ani F, Weisz S, Rozanski C, et al
    Prevention of venous thromboembolism in pregnant patients with a history of venous thromboembolic disease: A retrospective cohort study.
    Thromb Res. 2018;167:20-25.
    PubMed     Text format     Abstract available
    
    
    
38. TAKACH LAPNER S, Stevens SM, Woller SC, Snow G, et al
    Age-adjusted versus clinical probability-adjusted D-dimer to exclude pulmonary embolism.
    Thromb Res. 2018;167:15-19.
    PubMed     Text format     Abstract available
    
    
    April 2018
39. HUANG D, Chan PH, She HL, Wong CK, et al
    Secular trends and etiologies of venous thromboembolism in Chinese from 2004 to 2016.
    Thromb Res. 2018;166:80-85.
    PubMed     Text format     Abstract available
    
    
    
40. SUN X, Li J, Shi J
    Validating the Chinese version of the PEmb-QoL questionnaire: A measure for quality of life assessment after pulmonary embolism.
    Thromb Res. 2018;166:86-91.
    PubMed     Text format     Abstract available
    
    
    
41. SIRBU IV, Nistor DO, Hutanu A, Banescu C, et al
    Can the electrocardiogram be used for predicting risk in patients with acute pulmonary embolism?
    Thromb Res. 2018;166:76.
    PubMed     Text format    
    
    
    
42. YAMASHITA Y, Morimoto T, Toyota T, Shiomi H, et al
    Asian patients versus non-Asian patients in the efficacy and safety of direct oral anticoagulants relative to vitamin K antagonist for venous thromboembolism: A systemic review and meta-analysis.
    Thromb Res. 2018;166:37-42.
    PubMed     Text format     Abstract available
    
    
    
43. VAN ES N, Hisada Y, Di Nisio M, Cesarman G, et al
    Extracellular vesicles exposing tissue factor for the prediction of venous thromboembolism in patients with cancer: A prospective cohort study.
    Thromb Res. 2018;166:54-59.
    PubMed     Text format     Abstract available
    
    
    
44. ARROYO AB, de Los Reyes-Garcia AM, Teruel-Montoya R, Vicente V, et al
    microRNAs in the haemostatic system: More than witnesses of thromboembolic diseases?
    Thromb Res. 2018;166:1-9.
    PubMed     Text format     Abstract available
    
    
    
45. PARRY BA, Chang AM, Schellong SM, House SL, et al
    International, multicenter evaluation of a new D-dimer assay for the exclusion of venous thromboembolism using standard and age-adjusted cut-offs.
    Thromb Res. 2018;166:63-70.
    PubMed     Text format     Abstract available
    
    
    
46. BOVA C, Vanni S, Prandoni P, Morello F, et al
    A prospective validation of the Bova score in normotensive patients with acute pulmonary embolism.
    Thromb Res. 2018;165:107-111.
    PubMed     Text format     Abstract available
    
    
    
47. ROBIN P, Carrier M
    Revisiting occult cancer screening in patients with unprovoked venous thromboembolism.
    Thromb Res. 2018;164 Suppl 1:S7-S11.
    PubMed     Text format     Abstract available
    
    
    
48. LIEBMAN HA
    Cancer prognosis in patients with venous thromboembolism (VTE) and patients with clinical and laboratory biomarkers predictive of VTE risk.
    Thromb Res. 2018;164 Suppl 1:S19-S22.
    PubMed     Text format     Abstract available
    
    
    
49. PIRAN S, Schulman S
    Management of recurrent venous thromboembolism in patients with cancer: A review.
    Thromb Res. 2018;164 Suppl 1:S172-S177.
    PubMed     Text format     Abstract available
    
    
    
50. VERSO M, Franco L, Giustozzi M, Becattini C, et al
    Treatment of venous thromboembolism in patients with cancer: What news from clinical trials?
    Thromb Res. 2018;164 Suppl 1:S168-S171.
    PubMed     Text format     Abstract available
    
    
    
51. KIMPTON M, Wells PS, Carrier M
    Apixaban for the prevention of venous thromboembolism in high-risk ambulatory cancer patients receiving chemotherapy: Rational and design of the AVERT trial.
    Thromb Res. 2018;164 Suppl 1:S124-S129.
    PubMed     Text format     Abstract available
    
    
    
52. GRAN OV, Braekkan SK, Hansen JB
    Prothrombotic genotypes and risk of venous thromboembolism in cancer.
    Thromb Res. 2018;164 Suppl 1:S12-S18.
    PubMed     Text format     Abstract available
    
    
    
53. LYMAN GH, Culakova E, Poniewierski MS, Kuderer NM, et al
    Morbidity, mortality and costs associated with venous thromboembolism in hospitalized patients with cancer.
    Thromb Res. 2018;164 Suppl 1:S112-S118.
    PubMed     Text format     Abstract available
    
    
    March 2018
54. JOHANSSON M, Lind M, Jansson JH, Fharm E, et al
    Fasting plasma glucose, oral glucose tolerance test, and the risk of first-time venous thromboembolism. A report from the VEINS cohort study.
    Thromb Res. 2018;165:86-94.
    PubMed     Text format     Abstract available
    
    
    
55. OEDINGEN C, Scholz S, Razum O
    Systematic review and meta-analysis of the association of combined oral contraceptives on the risk of venous thromboembolism: The role of the progestogen type and estrogen dose.
    Thromb Res. 2018;165:68-78.
    PubMed     Text format     Abstract available
    
    
    
56. THURN L, Wikman A, Lindqvist PG
    Postpartum blood transfusion and hemorrhage as independent risk factors for venous thromboembolism.
    Thromb Res. 2018;165:54-60.
    PubMed     Text format     Abstract available
    
    
    
57. VOILS SA, Shahin MH, Garrett TJ, Frye RF, et al
    Metabolomic association between venous thromboembolism in critically ill trauma patients and kynurenine pathway of tryptophan metabolism.
    Thromb Res. 2018;165:6-13.
    PubMed     Text format     Abstract available
    
    
    
58. LEE YH, Cha SI, Shin KM, Lim JK, et al
    Clinical relevance of syncope in patients with pulmonary embolism.
    Thromb Res. 2018;164:85-89.
    PubMed     Text format     Abstract available
    
    
    
59. PESAVENTO R, Prandoni P
    Prevention and treatment of the chronic thromboembolic pulmonary hypertension.
    Thromb Res. 2018 Mar 2. pii: S0049-3848(18)30264.
    PubMed     Text format     Abstract available
    
    
    
60. PRASCA S, Carmona R, Ji L, Ko RH, et al
    Obesity and risk for venous thromboembolism from contemporary therapy for pediatric acute lymphoblastic leukemia.
    Thromb Res. 2018;165:44-50.
    PubMed     Text format     Abstract available
    
    
    
61. GAL GL, Righini M
    Preface to Diagnosis of venous thromboembolism.
    Thromb Res. 2018;163:200.
    PubMed     Text format    
    
    
    February 2018
62. QUEZADA CA, Bikdeli B, Barrios D, Morillo R, et al
    Assessment of coexisting deep vein thrombosis for risk stratification of acute pulmonary embolism.
    Thromb Res. 2018;164:40-44.
    PubMed     Text format     Abstract available
    
    
    
63. BRANCHFORD BR, Betensky M, Goldenberg NA
    Pediatric issues in thrombosis and hemostasis: The how and why of venous thromboembolism risk stratification in hospitalized children.
    Thromb Res. 2018 Feb 17. pii: S0049-3848(18)30072.
    PubMed     Text format     Abstract available
    
    
    
64. WILLICH SN, Chuang LH, van Hout B, Gumbs P, et al
    Pulmonary embolism in Europe - Burden of illness in relationship to healthcare resource utilization and return to work.
    Thromb Res. 2018;170:181-191.
    PubMed     Text format     Abstract available
    
    
    
65. KAHN SR, Pengo V
    Special issue: Late consequences of venous thromboembolism.
    Thromb Res. 2018 Feb 13. pii: S0049-3848(18)30067.
    PubMed     Text format    
    
    
    
66. JAFFRAY J, Rajpurkar M, Sharathkumar A, Patel K, et al
    Transition of care for patients with venous thromboembolism: Rationale, design and implementation of a quality intervention project conducted at American Thrombosis and Hemostasis Network (ATHN) affiliated sites.
    Thromb Res. 2018;163:146-152.
    PubMed     Text format     Abstract available
    
    
    January 2018
67. SAMUELSON BANNOW BT, Konkle BA
    Laboratory biomarkers for venous thromboembolism risk in patients with hematologic malignancies: A review.
    Thromb Res. 2018;163:138-145.
    PubMed     Text format     Abstract available
    
    
    
68. COLEMAN CI, Turpie AGG, Bunz TJ, Baker WL, et al
    Effectiveness and safety of outpatient rivaroxaban versus warfarin for treatment of venous thromboembolism in patients with a known primary hypercoagulable state.
    Thromb Res. 2018;163:132-137.
    PubMed     Text format     Abstract available
    
    
    
69. RODGER M, Langlois N, Middeldorp S, Kahn S, et al
    Initial strides for invent-VTE: Towards global collaboration to accelerate clinical research in venous thromboembolism.
    Thromb Res. 2018;163:128-131.
    PubMed     Text format     Abstract available
    
    
    
70. CASAZZA F, Pacchetti I, Rulli E, Roncon L, et al
    Prognostic significance of electrocardiogram at presentation in patients with pulmonary embolism of different severity.
    Thromb Res. 2018;163:123-127.
    PubMed     Text format     Abstract available
    
    
    
71. BEYER-WESTENDORF J
    What have we learned from real-world NOAC studies in venous thromboembolism treatment?
    Thromb Res. 2018;163:83-91.
    PubMed     Text format     Abstract available
    
    
    
72. VAN ES N, Louzada M, Carrier M, Tagalakis V, et al
    Predicting the risk of recurrent venous thromboembolism in patients with cancer: A prospective cohort study.
    Thromb Res. 2018;163:41-46.
    PubMed     Text format     Abstract available
    
    
    
73. FERNANDES T, Auger W, Fedullo P
    Epidemiology and risk factors for chronic thromboembolic pulmonary hypertension.
    Thromb Res. 2018 Jan 8. pii: S0049-3848(18)30012.
    PubMed     Text format    
    
    
    
74. SIUDUT J, Natorska J, Zabczyk M, Zajac D, et al
    Impaired plasminogen binding in patients with venous thromboembolism: Association with protein carbonylation.
    Thromb Res. 2018;163:12-18.
    PubMed     Text format     Abstract available
    
    
    
75. KARATHANOS C, Spanos K, Giannoukas A
    Residual pulmonary vascular obstruction as predictor of pulmonary embolism recurrence after a first unprovoked episode.
    Thromb Res. 2018;162:77-78.
    PubMed     Text format    
    
    
    December 2017
76. VANASSCHE T, Verhamme P, Wells PS, Segers A, et al
    Impact of age, comorbidity, and polypharmacy on the efficacy and safety of edoxaban for the treatment of venous thromboembolism: An analysis of the randomized, double-blind Hokusai-VTE trial.
    Thromb Res. 2017;162:7-14.
    PubMed     Text format     Abstract available
    
    
    
77. WAN T, Rodger M, Zeng W, Robin P, et al
    Residual pulmonary embolism as a predictor for recurrence after a first unprovoked episode: Results from the REVERSE cohort study.
    Thromb Res. 2017 Dec 7. pii: S0049-3848(17)30582.
    PubMed     Text format     Abstract available
    
    
    
78. JIMENEZ D, Nieto R, Corres J, Fernandez-Golfin C, et al
    Diclofenac for reversal of right ventricular dysfunction in acute normotensive pulmonary embolism: A pilot study.
    Thromb Res. 2017;162:1-6.
    PubMed     Text format     Abstract available
    
    
    November 2017
79. JIMENEZ D, Yusen RD
    Outpatient therapy for acute symptomatic pulmonary embolism diagnosed in the emergency department: Time to improve the evidence base.
    Thromb Res. 2017 Nov 26. pii: S0049-3848(17)30584.
    PubMed     Text format    
    
    
    
80. BACH AG, Taute BM, Surov A
    Time to threshold as a new indicator of circulatory state and prognosis in patients with pulmonary embolism.
    Thromb Res. 2017;161:26-32.
    PubMed     Text format     Abstract available
    
    
    
81. KLIL-DRORI AJ, Coulombe J, Suissa S, Hirsch A, et al
    Temporal trends in outpatient management of incident pulmonary embolism and associated mortality.
    Thromb Res. 2017 Nov 6. pii: S0049-3848(17)30542.
    PubMed     Text format     Abstract available
    
    
    October 2017
82. POPOOLA VO, Tavakoli F, Lau BD, Lankiewicz M, et al
    Exploring the impact of route of administration on medication acceptance in hospitalized patients: Implications for venous thromboembolism prevention.
    Thromb Res. 2017;160:109-113.
    PubMed     Text format     Abstract available
    
    
    
83. FALLER N, Stalder O, Limacher A, Bassetti S, et al
    Frequency of use and acceptability of clinical prediction rules for pulmonary embolism among Swiss general internal medicine residents.
    Thromb Res. 2017;160:9-13.
    PubMed     Text format     Abstract available
    
    
    
84. RATTAZZI M, Villalta S, De Lucchi L, Sponchiado A, et al
    Chronic kidney disease is associated with increased risk of venous thromboembolism recurrence.
    Thromb Res. 2017;160:32-37.
    PubMed     Text format     Abstract available
    
    
    
85. ZIA A, Russell J, Sarode R, Veeram SR, et al
    Markers of coagulation activation, inflammation and fibrinolysis as predictors of poor outcomes after pediatric venous thromboembolism: A systematic review and meta-analysis.
    Thromb Res. 2017;160:1-8.
    PubMed     Text format     Abstract available
    
    
    September 2017
86. ROBIN P, Le Roux PY, Tromeur C, Planquette B, et al
    Risk factors of occult malignancy in patients with unprovoked venous thromboembolism.
    Thromb Res. 2017;159:48-51.
    PubMed     Text format     Abstract available
    
    
    
87. KRISTOFFERSEN AH, Ajzner E, Bauca JM, Carraro P, et al
    Pre- and post-test probabilities of venous thromboembolism and diagnostic accuracy of D-dimer, estimated by European clinicians working in emergency departments.
    Thromb Res. 2017;159:19-23.
    PubMed     Text format    
    
    
    
88. KHARAT A, Hachulla AL, Noble S, Lador F, et al
    Modern diagnosis of chronic thromboembolic pulmonary hypertension.
    Thromb Res. 2017 Sep 9. pii: S0049-3848(17)30486.
    PubMed     Text format     Abstract available
    
    
    
89. BARRIOS D, Morillo R, Yusen RD, Jimenez D, et al
    Pulmonary embolism severity assessment and prognostication.
    Thromb Res. 2017 Sep 8. pii: S0049-3848(17)30485.
    PubMed     Text format     Abstract available
    
    
    
90. KNIGHT-PERRY J, Branchford BR, Thornhill D, Martiniano SL, et al
    Venous thromboembolism in children with cystic fibrosis: Retrospective incidence and intrapopulation risk factors.
    Thromb Res. 2017;158:161-166.
    PubMed     Text format     Abstract available
    
    
    
91. GADE IL, Braekkan S, Naess IA, Hansen JB, et al
    Epidemiology of venous thromboembolism in hematological cancers: The Scandinavian Thrombosis and Cancer (STAC) cohort.
    Thromb Res. 2017;158:157-160.
    PubMed     Text format     Abstract available
    
    
    
92. CHAN WS
    Diagnosis of venous thromboembolism in pregnancy.
    Thromb Res. 2017 Sep 5. pii: S0049-3848(17)30482.
    PubMed     Text format     Abstract available
    
    
    August 2017
93. MEZEI ZA, Katona E, Kallai J, Bereczky Z, et al
    Factor XIII levels and factor XIII B subunit polymorphisms in patients with venous thromboembolism.
    Thromb Res. 2017;158:93-97.
    PubMed     Text format     Abstract available
    
    
    
94. KONIGSBRUGGE O, Lorenz M, Auinger M, Schmaldienst S, et al
    Venous thromboembolism and vascular access thrombosis in patients with end-stage renal disease on maintenance hemodialysis: Cross-sectional results of the Vienna InVestigation of AtriaL fibrillation and thromboembolism in patients on hemoDIalysis (VIV
    Thromb Res. 2017;158:59-64.
    PubMed     Text format     Abstract available
    
    
    
95. EL-REFAI SM, Black EP, Adams VR, Talbert JC, et al
    Statin use and venous thromboembolism in cancer: A large, active comparator, propensity score matched cohort study.
    Thromb Res. 2017;158:49-58.
    PubMed     Text format     Abstract available
    
    
    July 2017
96. BAUERSACHS R, Agnelli G, Gitt AK, Monreal M, et al
    The role of heparin lead-in in the real-world management of acute venous thromboembolism: The PREFER in VTE registry.
    Thromb Res. 2017;157:181-188.
    PubMed     Text format     Abstract available
    
    
    
97. DZIKOWSKA-DIDUCH O, Domienik-Karlowicz J, Gorska E, Demkow U, et al
    E-selectin and sICAM-1, biomarkers of endothelial function, predict recurrence of venous thromboembolism.
    Thromb Res. 2017;157:173-180.
    PubMed     Text format     Abstract available
    
    
    
98. GHANIMA W, Wik HS, Tavoly M, Enden T, et al
    Late consequences of venous thromboembolism: Measuring quality of life after deep vein thrombosis and pulmonary embolism.
    Thromb Res. 2017 Jul 23. pii: S0049-3848(17)30434.
    PubMed     Text format     Abstract available
    
    
    
99. ZHOU M, Zhang L, Ding Y, Wang Y, et al
    Extensive screening for occult malignancy in unprovoked venous thromboembolism: A meta-analysis.
    Thromb Res. 2017;157:147-153.
    PubMed     Text format     Abstract available
    
    
    
100. PRANDONI P, Lensing AWA, Prins MH, Noventa F, et al
     Does the presence of clinical symptoms of pulmonary embolism affect the outcome of patients with deep vein thrombosis?
     Thromb Res. 2017;157:134-135.
     PubMed     Text format    
     
     
     June 2017
101. LE ROUX PY, Robin P, Salaun PY
     New developments and future challenges of nuclear medicine and molecular imaging for pulmonary embolism.
     Thromb Res. 2017 Jun 27. pii: S0049-3848(17)30394.
     PubMed     Text format     Abstract available
     
     
     
102. ARENDT JFH, Farkas DK, Pedersen L, Sorensen HT, et al
     Elevated plasma vitamin B12 levels and risk of venous thromboembolism among cancer patients: A population-based cohort study.
     Thromb Res. 2017;156:177-183.
     PubMed     Text format     Abstract available
     
     
     
103. WALEN S, Katerberg B, Boomsma MF, van den Berg JWK, et al
     Safety, feasibility and patient reported outcome measures of outpatient treatment of pulmonary embolism.
     Thromb Res. 2017;156:172-176.
     PubMed     Text format     Abstract available
     
     
     
104. WAN T, Skeith L, Karovitch A, Rodger M, et al
     Guidance for the diagnosis of pulmonary embolism during pregnancy: Consensus and controversies.
     Thromb Res. 2017;157:23-28.
     PubMed     Text format     Abstract available
     
     
     
105. HELLMAN T, Kiviniemi T, Nuotio I, Vasankari T, et al
     Intensity of anticoagulation and risk of thromboembolism after elective cardioversion of atrial fibrillation.
     Thromb Res. 2017;156:163-167.
     PubMed     Text format     Abstract available
     
     
     
106. KRUGER S, Haas M, Burkl C, Goehring P, et al
     Incidence, outcome and risk stratification tools for venous thromboembolism in advanced pancreatic cancer - A retrospective cohort study.
     Thromb Res. 2017;157:9-15.
     PubMed     Text format     Abstract available
     
     
     
107. SISTA AK, Klok FA
     Late outcomes of pulmonary embolism: The post-PE syndrome.
     Thromb Res. 2017 Jun 16. pii: S0049-3848(17)30381.
     PubMed     Text format     Abstract available
     
     
     
108. MA Y, Wang Y, Liu D, Ning Z, et al
     A safe strategy to rule out pulmonary embolism: The combination of the Wells score and D-dimer test: One prospective study.
     Thromb Res. 2017;156:160-162.
     PubMed     Text format    
     
     
     
109. SHARMA S, Lang IM
     Current understanding of the pathophysiology of chronic thromboembolic pulmonary hypertension.
     Thromb Res. 2017 Jun 12. pii: S0049-3848(17)30375.
     PubMed     Text format     Abstract available
     
     
     
110. DONADINI MP, Dentali F, Castellaneta M, Gnerre P, et al
     Pulmonary embolism prognostic factors and length of hospital stay: A cohort study.
     Thromb Res. 2017;156:155-159.
     PubMed     Text format     Abstract available
     
     
     
111. MANSOUR S, Alotaibi G, Wu C, McMurtry MS, et al
     Trends in admission rates and in-hospital stay for venous thromboembolism.
     Thromb Res. 2017;156:149-154.
     PubMed     Text format     Abstract available
     
     
     
112. AL MEGREN M, De Wit C, Al Qahtani M, Le Gal G, et al
     Management of venous thromboembolism in patients with glioma.
     Thromb Res. 2017;156:105-108.
     PubMed     Text format     Abstract available
     
     
     
113. KLINE JA
     Diagnosis and Exclusion of Pulmonary Embolism.
     Thromb Res. 2017 Jun 7. pii: S0049-3848(17)30358.
     PubMed     Text format     Abstract available
     
     
     
114. KONSTANTINIDES SV, Barco S
     Prevention of early complications and late consequences after acute pulmonary embolism: Focus on reperfusion techniques.
     Thromb Res. 2017 Jun 1. pii: S0049-3848(17)30352.
     PubMed     Text format     Abstract available
     
     
     
115. HUSSEINZADEH H, Carrier M
     Occult cancer detection in patients with hemostatic disorder and venous thromboembolism.
     Thromb Res. 2017 Jun 1. pii: S0049-3848(17)30354.
     PubMed     Text format     Abstract available
     
     
     May 2017
116. LIEDL G, Nazerian P, Pepe G, Caviglioli C, et al
     Different time course of plasma lactate, troponin I and Nt-proBNP concentrations in patients with acute pulmonary embolism.
     Thromb Res. 2017;156:26-28.
     PubMed     Text format    
     
     
     
117. BARCO S, Konstantinides S, Huisman MV, Klok FA, et al
     Diagnosis of recurrent venous thromboembolism.
     Thromb Res. 2017 May 26. pii: S0049-3848(17)30344.
     PubMed     Text format     Abstract available
     
     
     
118. LUONG NV, Kroll MH, Vu K
     Recurrence of venous thromboembolism among adults acute leukemia patients treated at the University of Texas MD Anderson Cancer Center: Incidence and risk factors.
     Thromb Res. 2017;156:14-19.
     PubMed     Text format     Abstract available
     
     
     
119. TRITSCHLER T, Aujesky D
     Venous thromboembolism in the elderly: A narrative review.
     Thromb Res. 2017;155:140-147.
     PubMed     Text format     Abstract available
     
     
     
120. REZANIA S, Puskarich MA, Petrusca DN, Neto-Neves EM, et al
     Platelet hyperactivation, apoptosis and hypercoagulability in patients with acute pulmonary embolism.
     Thromb Res. 2017;155:106-115.
     PubMed     Text format     Abstract available
     
     
     
121. ROY PM, Moumneh T, Penaloza A, Sanchez O, et al
     Outpatient management of pulmonary embolism.
     Thromb Res. 2017;155:92-100.
     PubMed     Text format     Abstract available
     
     
     
122. WASSEF A, Lim W, Wu C
     Indications, complications and outcomes of inferior vena cava filters: A retrospective study.
     Thromb Res. 2017;153:123-128.
     PubMed     Text format     Abstract available
     
     
     April 2017
123. ROBIN P, Le Roux PY, Le Moigne E, Planquette B, et al
     Additional testing following screening strategies for occult malignancy diagnosis in patients with unprovoked venous thromboembolism.
     Thromb Res. 2017;155:6-9.
     PubMed     Text format     Abstract available
     
     
     
124. DITTMAR M, Smith N, Warren B, Clark B, et al
     Improved sensitivity and specificity of pediatric hospital-acquired venous thromboembolism case identification by addition of radiographic and pharmacologic elements.
     Thromb Res. 2017;154:93-95.
     PubMed     Text format    
     
     
     
125. LANGE N, Stalder O, Aujesky D
     Is clinical pre-test probability assessment for venous thromboembolism underused?
     Thromb Res. 2017;155:10-11.
     PubMed     Text format    
     
     
     
126. KEVANE B, Ainle FN
     Contraception and menstrual bleeding during venous thromboembolism treatment: Does current practice reflect expert option?
     Thromb Res. 2017 Apr 12. pii: S0049-3848(17)30281.
     PubMed     Text format    
     
     
     
127. CHU JN, Maselli J, Auerbach AD, Fang MC, et al
     The risk of venous thromboembolism with aspirin compared to anticoagulants after hip and knee arthroplasty.
     Thromb Res. 2017;155:65-71.
     PubMed     Text format     Abstract available
     
     
     
128. SQUIZZATO A, Pomero F, Allione A, Priotto R, et al
     Diagnostic accuracy of magnetic resonance imaging in patients with suspected pulmonary embolism: A bivariate meta-analysis.
     Thromb Res. 2017;154:64-72.
     PubMed     Text format     Abstract available
     
     
     March 2017
129. GON Y, Sakaguchi M, Takasugi J, Mochizuki H, et al
     Ischemic stroke in cancer patients treated with direct oral anticoagulants for venous thromboembolism.
     Thromb Res. 2017;154:16-18.
     PubMed     Text format     Abstract available
     
     
     
130. KLOK FA, Schreiber K, Stach K, Ageno W, et al
     Oral contraception and menstrual bleeding during treatment of venous thromboembolism: Expert opinion versus current practice: Combined results of a systematic review, expert panel opinion and an international survey.
     Thromb Res. 2017;153:101-107.
     PubMed     Text format     Abstract available
     
     
     
131. BRUNSON A, Ho G, White R, Wun T, et al
     Inferior vena cava filters in patients with cancer and venous thromboembolism (VTE) does not improve clinical outcomes: A population-based study.
     Thromb Res. 2017;153:57-64.
     PubMed     Text format     Abstract available
     
     
     
132. BEYAN C, Beyan E
     Mean platelet volume may not be an alternative test instead of platelet aggregation in patients with venous thromboembolism.
     Thromb Res. 2017;153:50.
     PubMed     Text format    
     
     
     
133. MA K, Kahn SR, Hirsch AM, Akaberi A, et al
     N-terminal of prohormone brain natriuretic peptide predicts functional limitation one year following pulmonary embolism: Results from the ELOPE study.
     Thromb Res. 2017;153:47-49.
     PubMed     Text format    
     
     
     
134. RUHLE F, Stoll M
     Genetic factors in pediatric venous thromboembolism.
     Thromb Res. 2017;151 Suppl 1:S97-S99.
     PubMed     Text format     Abstract available
     
     
     
135. BARCO S, Konstantinides SV
     Risk-adapted management of pulmonary embolism.
     Thromb Res. 2017;151 Suppl 1:S92-S96.
     PubMed     Text format     Abstract available
     
     
     
136. TROMEUR C, van der Pol LM, Klok FA, Couturaud F, et al
     Pitfalls in the diagnostic management of pulmonary embolism in pregnancy.
     Thromb Res. 2017;151 Suppl 1:S86-S91.
     PubMed     Text format     Abstract available
     
     
     
137. BLANCO-MOLINA A, Trujillo-Santos J, Pesavento R, Rosa V, et al
     Outcome after discontinuing anticoagulant therapy in women with venous thromboembolism during hormonal use.
     Thromb Res. 2017;151 Suppl 1:S6-S10.
     PubMed     Text format     Abstract available
     
     
     
138. MARTIN-MARTOS F, Trujillo-Santos J, Del Toro J, Bura-Riviere A, et al
     Gender differences in patients with venous thromboembolism and five common sites of cancer.
     Thromb Res. 2017;151 Suppl 1:S16-S20.
     PubMed     Text format     Abstract available
     
     
     
139. TZORAN I, Papadakis E, Brenner B, Valle R, et al
     Gender-related differences in the outcome of patients with venous thromboembolism and thrombophilia.
     Thromb Res. 2017;151 Suppl 1:S11-S15.
     PubMed     Text format     Abstract available
     
     
     
140. MOUSTAFA F, Fernandez S, Fernandez-Capitan C, Nieto JA, et al
     Uterine bleeding during anticoagulation in women with venous thromboembolism.
     Thromb Res. 2017;151 Suppl 1:S1-S5.
     PubMed     Text format     Abstract available
     
     
     February 2017
141. VAN ES N, Wells PS, Carrier M
     Bleeding risk in patients with unprovoked venous thromboembolism: A critical appraisal of clinical prediction scores.
     Thromb Res. 2017;152:52-60.
     PubMed     Text format     Abstract available
     
     
     
142. WILTS IT, Le Gal G, Den Exter PL, Van Es J, et al
     Performance of the age-adjusted cut-off for D-dimer in patients with cancer and suspected pulmonary embolism.
     Thromb Res. 2017;152:49-51.
     PubMed     Text format     Abstract available
     
     
     
143. THEBERGE I, Bowdridge J, Forgie MA, Carrier M, et al
     Rivaroxaban shows promise as effective therapy for cancer patients with venous thromboembolic disease.
     Thromb Res. 2017;152:4-6.
     PubMed     Text format    
     
     
     
144. NOJIMA J, Motoki Y, Hara K, Sakata T, et al
     Detection of antibodies against domain 1 of beta2-glycoprotein I is key in predicting thromboembolic complications in patients with systemic lupus erythematosus.
     Thromb Res. 2017;153:83-84.
     PubMed     Text format    
     
     
     January 2017
145. KHORANA AA, Francis CW, Kuderer NM, Carrier M, et al
     Dalteparin thromboprophylaxis in cancer patients at high risk for venous thromboembolism: A randomized trial.
     Thromb Res. 2017 Jan 26. pii: S0049-3848(17)30020.
     PubMed     Text format     Abstract available
     
     
     
146. PUURUNEN MK, Hwang SJ, O'Donnell CJ, Tofler G, et al
     Platelet function as a risk factor for venous thromboembolism in the Framingham Heart Study.
     Thromb Res. 2017;151:57-62.
     PubMed     Text format     Abstract available
     
     
     
147. COWAN LT, Lutsey PL, Pankow JS, Cushman M, et al
     Hospitalization with infection and incident venous thromboembolism: The ARIC study.
     Thromb Res. 2017;151:74-78.
     PubMed     Text format     Abstract available
     
     
     
148. COYLE K, Carrier M, Lazo-Langner A, Shivakumar S, et al
     Cost effectiveness of the addition of a comprehensive CT scan to the abdomen and pelvis for the detection of cancer after unprovoked venous thromboembolism.
     Thromb Res. 2017;151:67-71.
     PubMed     Text format     Abstract available
     
     
     
149. KUO TH, Li HY, Lin SH
     Acute kidney injury and risk of deep vein thrombosis and pulmonary embolism in Taiwan: A nationwide retrospective cohort study.
     Thromb Res. 2017;151:29-35.
     PubMed     Text format     Abstract available
     
     
     
150. ENDE-VERHAAR YM, Huisman MV, Klok FA
     To screen or not to screen for chronic thromboembolic pulmonary hypertension after acute pulmonary embolism.
     Thromb Res. 2017;151:1-7.
     PubMed     Text format     Abstract available
     
     
     December 2016
151. ZOLLER B, Li X, Ohlsson H, Sundquist J, et al
     Seasonal variation of pulmonary embolism and age dependence.
     Thromb Res. 2016;150:76-77.
     PubMed     Text format    
     
     
     
152. ROSS JA, Miller MM, Rojas Hernandez CM
     Comparative effectiveness and safety of direct oral anticoagulants (DOACs) versus conventional anticoagulation for the treatment of cancer-related venous thromboembolism: A retrospective analysis.
     Thromb Res. 2016;150:86-89.
     PubMed     Text format     Abstract available
     
     
     
153. VAN ES N, Franke VF, Middeldorp S, Wilmink JW, et al
     The Khorana score for the prediction of venous thromboembolism in patients with pancreatic cancer.
     Thromb Res. 2016;150:30-32.
     PubMed     Text format     Abstract available
     
     
     
154. SWIER N, Versteeg HH
     Reciprocal links between venous thromboembolism, coagulation factors and ovarian cancer progression.
     Thromb Res. 2016;150:8-18.
     PubMed     Text format     Abstract available
     
     
     
155. OZCAN CETIN EH, Cetin MS, Canpolat U, Akdi A, et al
     Platelet-to-lymphocyte ratio as a novel marker of in-hospital and long-term adverse outcomes among patients with acute pulmonary embolism: A single center large-scale study.
     Thromb Res. 2016;150:33-40.
     PubMed     Text format     Abstract available
     
     
     
156. PIOVELLA F, Iosub DI
     Extended non-vitamin K antagonist oral anticoagulation therapy for prevention of recurrent venous thromboembolism.
     Thromb Res. 2016 Dec 7. pii: S0049-3848(16)30645.
     PubMed     Text format     Abstract available
     
     
     
157. GARCIA-HORTON A, Kovacs MJ, Abdulrehman J, Taylor JE, et al
     Impact of thrombophilia screening on venous thromboembolism management practices.
     Thromb Res. 2016;149:76-80.
     PubMed     Text format     Abstract available
     
     
     November 2016
158. OLIE V, Bonaldi C
     Pulmonary embolism: Does the seasonal effect depend on age? A 12-year nationwide analysis of hospitalization and mortality.
     Thromb Res. 2016 Nov 30. pii: S0049-3848(16)30640.
     PubMed     Text format     Abstract available
     
     
     
159. LIN CL, Lin CL, Tzeng SL, Chung WS, et al
     Aplastic anemia and risk of deep vein thrombosis and pulmonary embolism: A nationwide cohort study.
     Thromb Res. 2016;149:70-75.
     PubMed     Text format     Abstract available
     
     
     
160. BURWEN DR, Wu C, Cirillo D, Rossouw JE, et al
     Venous thromboembolism incidence, recurrence, and mortality based on Women's Health Initiative data and Medicare claims.
     Thromb Res. 2016;150:78-85.
     PubMed     Text format     Abstract available
     
     
     October 2016
161. PLANQUETTE B, Ferre A, Peron J, Vial-Dupuy A, et al
     Residual pulmonary vascular obstruction and recurrence after acute pulmonary embolism. A single center cohort study.
     Thromb Res. 2016;148:70-75.
     PubMed     Text format     Abstract available
     
     
     
162. ALEXANDER M, Burbury K
     A systematic review of biomarkers for the prediction of thromboembolism in lung cancer - Results, practical issues and proposed strategies for future risk prediction models.
     Thromb Res. 2016;148:63-69.
     PubMed     Text format     Abstract available
     
     
     
163. BEYER-WESTENDORF J
     Letter to the Editor "Gender related aspects of bleeding with rivaroxaban in venous thromboembolism - Potential for pitfalls": A comment to "Impact of gender on safety and efficacy of rivaroxaban in adolescents & young adults with venous thromboem
     Thromb Res. 2016 Oct 26. pii: S0049-3848(16)30601.
     PubMed     Text format    
     
     
     
164. ZOLLER B, Ohlsson H, Sundquist J, Sundquist K, et al
     A sibling based design to quantify genetic and shared environmental effects of venous thromboembolism in Sweden.
     Thromb Res. 2016 Oct 20. pii: S0049-3848(16)30587.
     PubMed     Text format     Abstract available
     
     
     
165. KANG J, Lee JS, Lee JH, Lee KM, et al
     Recurrent pulmonary embolism during dabigatran treatment in a patient with immune thrombocytopenic purpura.
     Thromb Res. 2016;148:23-24.
     PubMed     Text format    
     
     
     
166. MELANCON T, Bivona C, Klenke S, Rockey M, et al
     Comparison of postoperative venous thromboembolism incidence in gastrointestinal and gynecologic solid tumors.
     Thromb Res. 2016;147:104-107.
     PubMed     Text format     Abstract available
     
     
     
167. RABINOVICH E, Bartholomew JR, Wilks ML, Tripp BL, et al
     Centralizing care of cancer-associated thromboembolism: The Cleveland Clinic experience.
     Thromb Res. 2016;147:102-103.
     PubMed     Text format    
     
     
     
168. PIRAN S, Schulman S
     Incidence and risk factors for venous thromboembolism in patients with acute spinal cord injury: A retrospective study.
     Thromb Res. 2016;147:97-101.
     PubMed     Text format     Abstract available
     
     
     September 2016
169. CORRAINI P, Ording AG, Henderson VW, Szepligeti S, et al
     Cancer, other comorbidity, and risk of venous thromboembolism after stroke: a population-based cohort study.
     Thromb Res. 2016;147:88-93.
     PubMed     Text format     Abstract available
     
     
     
170. VINSON DR, Ballard DW, Mark DG, Huang J, et al
     Risk stratifying emergency department patients with acute pulmonary embolism: Does the simplified Pulmonary Embolism Severity Index perform as well as the original?
     Thromb Res. 2016;148:1-8.
     PubMed     Text format     Abstract available
     
     
     
171. DEMELO-RODRIGUEZ P, Postigo-Esteban A, Garcia-Fernandez-Bravo I, Agud M, et al
     Evaluation of the SAMe-TT2R2 score to predict the quality of anticoagulation control in a cohort of patients with venous thromboembolism treated with vitamin K antagonists.
     Thromb Res. 2016;147:58-60.
     PubMed     Text format     Abstract available
     
     
     
172. VOILS SA, Lemon SJ, Jordan J, Riley P, et al
     Early thrombin formation capacity in trauma patients and association with venous thromboembolism.
     Thromb Res. 2016;147:13-15.
     PubMed     Text format     Abstract available
     
     
     
173. BLEKER SM, Beenen LF, Di Nisio M, van Es N, et al
     Incidental pulmonary embolism in cancer patients: Interobserver agreement on the diagnosis and extent with a focus on distal clots.
     Thromb Res. 2016;147:46-51.
     PubMed     Text format     Abstract available
     
     
     
174. ARACHCHILLAGE D, Reynolds R, Devey T, Maclean R, et al
     Effect of extremes of body weight on drug level in patient treated with standard dose of rivaroxaban for venous thromboembolism; real life experience.
     Thromb Res. 2016;147:32-35.
     PubMed     Text format    
     
     
     
175. KRAUSE M, Henningsen A, Torge A, Juhl D, et al
     Impact of gender on safety and efficacy of Rivaroxaban in adolescents & young adults with venous thromboembolism.
     Thromb Res. 2016 Sep 13. pii: S0049-3848(16)30542.
     PubMed     Text format    
     
     
     May 2016
176. NICKEL KF, Labberton L, Long AT, Langer F, et al
     The polyphosphate/factor XII pathway in cancer-associated thrombosis: novel perspectives for safe anticoagulation in patients with malignancies.
     Thromb Res. 2016;141 Suppl 2:S4-7.
     PubMed     Text format     Abstract available
     
     
     
177. GAUTHIER K, Le Gal G, Shivakumar S, Anderson D, et al
     Inter-observer reliability of the HERDOO2 clinical decision rule.
     Thromb Res. 2016;141:136-8.
     PubMed     Text format    
     
     
     February 2016
178. OLIVIER CB, Weik P, Meyer M, Weber S, et al
     TRAP-induced platelet aggregation is enhanced in cardiovascular patients receiving dabigatran.
     Thromb Res. 2016;138:63-8.
     PubMed     Text format     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Venous Thrombosis is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: